Skip to main content

China-related matters · Research first

For lawyers/Contact/Log in
China Legal PortalResearch · Routes · Counsel
Ask a lawyer

Search the portal

Legal signal newsroom

What changed—and why it matters for China-connected work.

Dated analysis of legal developments. Recency is not automatically importance: the lead pieces below are editorially selected for practical impact.

Browse the archive Evergreen national guides
Selected analysisEditorial

Real Property

Foreign Investment in Forestry Land Development and Urban Renewal in China: A Legal Guide for International Investors

Under China's Constitution and Land Administration Law, all land in China is either state-owned or collectively owned. Forestland in Heilongjiang is predomin…

Read featured analysis →
01Editorially selectedPractical impact before publishing order.
02Published vs updatedDates map to verified content fields.
03Bridge to evergreen researchInsights lead back to durable guides.

Archive dispatches

Latest legal signals

12 analyses on this page.

Data Privacy
Legally reviewed · 11 Aug 2026

Navigating EU Data Protection and Privacy in Outbound M&A and Investment: A Strategic Compliance Guide for Chinese Investors

6 min readRead analysis →
Finance & Tax
Legally reviewed · 9 Aug 2026

Paying Staff in the UK: PAYE, NIC, RTI and IR35 for Chinese Employers

11 min readRead analysis →
Employment
Legally reviewed · 9 Aug 2026

Hiring in the UK: Subsidiary, EOR or Agency Planning for Chinese Companies

11 min readRead analysis →
Data Privacy
Legally reviewed · 9 Aug 2026

GDPR for Chinese Companies: DPO, EU Representative and the China-Return Data Flow

11 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

After an FDA Warning Letter: Aligning Customer Notices with CAPA (Without Creating New Lies)

10 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Black Box / Boxed Warnings in China: Why Strong Label Language Is Not Automatic Immunity

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Academic Conference Speaker Fees in China Healthcare: An FMV File That Survives Scrutiny

9 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Two-Invoice Pressure After VBP: Redesigning Pharma Device Channels Without Building a Paper CSO

9 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Medical Representative Off-Label Push: When Manufacturer “Joint” Risk Becomes Real

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Real-World Evidence Projects in China: Privacy and Secondary-Use Traps for Global RWE Teams

10 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

CRO Enrollment Lag in China Trials: Drafting Liquidated Damages That Survive the Blame Game

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

CSO Marketing Fees in China Pharma: The Substance Test Before the Invoice Chain Burns You

8 min readRead analysis →

Signal to framework

A development is useful only when you can place it in the wider legal framework.

Use the national guides for the durable architecture behind a news event, then return here when a development changes the practical question.

Explore legal guides →